Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;21(9):900-909.
doi: 10.6004/jnccn.2023.0046.

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023

Therese B Bevers  1 , Bethany L Niell  2 , Jennifer L Baker  3 , Debbie L Bennett  4 , Ermelinda Bonaccio  5 , Melissa S Camp  6 , Sona Chikarmane  7 , Emily F Conant  8 , Mohammad Eghtedari  9 , Meghan R Flanagan  10 , Jeffrey Hawley  11 , Mark Helvie  12 , Linda Hodgkiss  13 , Tamarya L Hoyt  14 , Jennifer Ivanovich  15 , Maxine S Jochelson  16 , Swati Kulkarni  17 , Rachael B Lancaster  18 , Caitlin Mauer  19 , Jessica Maxwell  20 , Bhavika K Patel  21 , Mark Pearlman  12 , Liane Philpotts  22 , Donna Plecha  23 , Jennifer K Plichta  24 , Shadi Shakeri  25 , Mary Lou Smith  26 , Clarie L Streibert  27 , Roberta M Strigel  28 , Lusine Tumyan  29 , Nicole S Winkler  30 , Dulcy E Wolverton  31 , Mary Anne Bergman  32 , Rashmi Kumar  32 , Katie Stehman  32
Affiliations

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023

Therese B Bevers et al. J Natl Compr Canc Netw. 2023 Sep.

Abstract

The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer Screening and Diagnosis Panel is composed of a multidisciplinary team of experts in the field, including representation from medical oncology, gynecologic oncology, surgical oncology, internal medicine, family practice, preventive medicine, pathology, diagnostic and interventional radiology, as well as patient advocacy. The NCCN Breast Cancer Screening and Diagnosis Panel meets at least annually to review emerging data and comments from reviewers within their institutions to guide updates to existing recommendations. These NCCN Guidelines Insights summarize the panel's decision-making and discussion surrounding the most recent updates to the guideline's screening recommendations.

PubMed Disclaimer

LinkOut - more resources